The protective efficacy of a recombinant VP2-based African horsesickness subunit vaccine candidate is determined by adjuvant

Author: Scanlen M.   Paweska J.T.   Verschoor J.A.   van Dijk A.A.  

Publisher: Elsevier

ISSN: 0264-410X

Source: Vaccine, Vol.20, Iss.7, 2002-01, pp. : 1079-1088

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content